Case Study: Myllia Biotechnology streamlines CRISPR screening with eLabNext

Myllia Biotechnology GmbH streamlines CRISPR screening with eLabNext for a team of 30 scientists

Myllia Biotechnology GmbH, a growth-stage biotech company specializing in CRISPR screening, faced challenges with inefficient paper-based lab journals that hindered searchability, organization, and collaboration. To support its evolving research needs and prepare for future growth, the company sought a more structured and accessible form of documentation and turned to eLabNext's SciSure platform for a solution.

By implementing eLabNext's SciSure ELN and LIMS, Myllia gained a centralized platform that significantly enhanced data organization and provided robust sample tracking. The solution streamlined the recording of complex CRISPR projects and revolutionized sample management, offering comprehensive visibility into usage and associated data. Furthermore, eLabNext fostered a more collaborative environment by simplifying protocol management and making experiments readily accessible to all team members, thereby increasing efficiency and compliance.

Myllia Biotechnology GmbH